Inflammation and Cardiac Diseases de Giora Z. Feuerstein

Inflammation and Cardiac Diseases: Progress in Inflammation Research

Giora Z. Feuerstein

Peter Libby

Douglas L. Mann

en Limba Engleză Paperback – 23 oct 2012

Heart failure research is a most active area of research in academic, industrial and government-sponsored research and receives intense clinical attention. The recent recognition that inflammation is a risk factor and prognostic factor for heart disease has laid ground for preventive medicine and even anti-infective strategies in prevention and treatment of heart failure.

Citește tot Restrânge

	Preț	Express
Paperback (1)	1165^.19 lei 6-8 săpt.
Birkhäuser Basel – 23 oct 2012	1165^.19 lei 6-8 săpt.
Hardback (1)	1116^.73 lei 6-8 săpt.
Birkhäuser Basel – 25 aug 2003	1116^.73 lei 6-8 săpt.

Preț

Express

Paperback (1)

1165^.19 lei 6-8 săpt.

Birkhäuser Basel – 23 oct 2012

1165^.19 lei 6-8 săpt.

Hardback (1)

1116^.73 lei 6-8 săpt.

Birkhäuser Basel – 25 aug 2003

1116^.73 lei 6-8 săpt.

Din seria Progress in Inflammation Research

5%

Preț: 1615^.04 lei
5%

Preț: 1433^.10 lei
5%

Preț: 723^.05 lei
18%

Preț: 950^.21 lei
15%

Preț: 648^.42 lei
5%

Preț: 1300^.72 lei
5%

Preț: 1103^.95 lei
5%

Preț: 1061^.93 lei
5%

Preț: 715^.35 lei
5%

Preț: 1098^.63 lei
5%

Preț: 657^.90 lei
5%

Preț: 717^.93 lei
5%

Preț: 996^.71 lei
5%

Preț: 1413^.72 lei
5%

Preț: 1102^.46 lei
5%

Preț: 1102^.82 lei
5%

Preț: 991^.70 lei
5%

Preț: 1115^.86 lei
5%

Preț: 720^.31 lei
5%

Preț: 1611^.76 lei
5%

Preț: 654^.23 lei
5%

Preț: 1414^.64 lei
5%

Preț: 652^.77 lei
5%

Preț: 1099^.94 lei
5%

Preț: 1856^.59 lei
15%

Preț: 644^.95 lei
5%

Preț: 1108^.72 lei
5%

Preț: 658^.46 lei
5%

Preț: 1108^.51 lei
24%

Preț: 801^.38 lei
5%

Preț: 715^.19 lei
5%

Preț: 1807^.08 lei
5%

Preț: 721^.40 lei
5%

Preț: 991^.70 lei
5%

Preț: 720^.68 lei
5%

Preț: 1100^.09 lei
15%

Preț: 577^.87 lei
5%

Preț: 652^.77 lei
5%

Preț: 653^.35 lei
5%

Preț: 650^.25 lei
5%

Preț: 1116^.73 lei
5%

Preț: 1096^.98 lei
5%

Preț: 1412^.62 lei
5%

Preț: 1420^.49 lei
5%

Preț: 721^.77 lei
5%

Preț: 1102^.10 lei
5%

Preț: 1099^.20 lei

Cuprins

Inflammation – a new frontier in cardiac disease and therapeutics.- Pathological aspects and inflammation biomarkers in cardiac diseases.- A biomarker of inflammation in cardiovascular diseases.- Inflammation and coronary artery disease.- Inflammatory cells and their metalloproteinases in cardiac diseases.- The role of matrix metalloproteinases in LV remodeling following myocardial infarction.- Matrix metalloproteinases in heart failure: evidence from experimental models.- Inflammatory cytokines in cardiac diseases.- The clinical experience with anti-cytokine therapy in heart failure.- The role of IL-6 and related cytokines in myocardial remodeling and inflammation – implication for cardiac hypertrophy and heart failure.- Toll-like receptors and the cardiovascular system.- The role of IL-6 in experimental and clinical heart failure.- Oxygen and nitrogen reactive radicals in cardiac inflammation and disease.- Myocardial nitric oxide in cardiac remodeling.- Identification and role of inflammatory oxygen free radicals in cardiac ischemia and reperfusion injury.- The immune and complement system and cardiac diseases.- Immune-mediated myocarditis and interleukin-10.- Immunomodulation in heart failure: experimental models.- The role of complement in myocardial inflammation and reperfusion injury.- Inflammatory signaling pathways in cardiac diseases.- The role of immune and inflammatory cytokines in ischemic preconditioning of the heart – identification of novel cardiac cell survival signaling programs.- Stress-activated signals and their role in myocardial ischemia.- p38 MAPK in cardiac remodeling and failure: cytokine signaling and beyond.- Inflammation and myocarditis.- Inflammation and myocarditis.- The inflammatory process in experimental myocarditis.- Nuclearfactors in cardiac disease.- Peroxisome proliferator activated receptors, inflammation, the vasculature and the heart.- Chemokines and cardiac diseases.- Role of chemokines in the pathogenesis of congestive heart failure.- Neurohormonal mediators and cardiac inflammation.- The role of endothelin-1 in myocardial inflammation and fibrosis.- Cyclooxygenases and cardiac diseases.- Cyclo-oxygenase-2 and myocardial ischemia.- Inflammation and arrhythmias.- Inflammation as a cause and consequence of atrial fibrillation.- Summary: Immune and inflammatory modulators as potential therapeutic targets for cardiac diseases.